483 Hetero Labs - Unit IX May 2019

483 Hetero Labs - Unit IX May 2019

Concepcion Cruz FDA, Rajiv Srivastava FDA$119.00 - Available Now

FDA investigators audited the Hetero Labs - Unit IX - Visakhapatnam, India facility and issued inspectional observations (via FDA 483) on 14 May 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 14 May 2019
  • Location: Visakhapatnam, India
  • FEI: 3009093782
Add To Cart